Peptide library › Immune & inflammation
Icatibant
Also known as Firazyr, Sajazir
Self-injected treatment for sudden swelling attacks in hereditary angioedema.
What people use it for
- Acute attacks of hereditary angioedema
What Icatibant does in the body
Blocks the bradykinin B2 receptor, so bradykinin can't cause the leaky blood vessels and swelling of an attack.
Strength of evidence
Strong: Phase 3 trials (FAST-1, FAST-2 and FAST-3).
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Injection-site pain, redness and swelling (very common)
- Dizziness and headache
- Nausea
Who should avoid it or take extra care
- Recent heart attack or stroke needs caution
- Pregnancy or breastfeeding, unless a specialist advises it
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
FDA-approved in 2011; generic versions are available. Can be self-injected after training.
How it's taken
Route: Injection under the skin of the abdomen during an attack
How long it lasts (half-life): About 1.5 hours
Latest research & news
- National survey of the clinical profile and management of patients with hereditary angioedema due to C1-inhibitor deficiency in Colombia
Research · Study · PubMed · Immunol Res · 17 Nov 2026
Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.
Keep track of Icatibant privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Icatibant in Fiala How to installMore in Immune & inflammation
- Thymosin Alpha-1Thymus-derived immune-modulating peptide approved in several countries.
- LL-37The only human cathelicidin: an antimicrobial peptide made by the immune system.
- KPVAnti-inflammatory tripeptide taken from the end of alpha-MSH.
- VIPNeuropeptide that relaxes blood vessels and calms immune responses.
- ARA-290Peptide derived from erythropoietin (EPO), studied for nerve pain and inflammation without raising red blood cells.
- CyclosporineRing-shaped peptide from a fungus that suppresses the immune system; used after transplants and for psoriasis, arthritis and dry eye.
- ThymulinNatural thymus hormone sold online for immune support and hair growth; no modern human trials.
- NangibotideExperimental drip for septic shock that aims to calm an overactive immune response; it missed its main trial goal.
- EcallantideInjection that stops attacks of hereditary angioedema, a rare condition causing sudden severe swelling.
- ZilucoplanDaily self-injected peptide for generalised myasthenia gravis, an autoimmune condition that causes muscle weakness.